FindTrial
Sign In

Patch testing with extended series of allergens in allergic contact dermatitis

Patch testing with an extended standard series in patients undergoing patch test with Indian Standard Series for suspected Allergic contact dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016110
Enrollment
40
Registered
2018-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L239- Allergic contact dermatitis, unspecified cause

Interventions

Intervention1: patch test allergens: 56 patch test allergens will be added in total, which will include 25 of the already existing Indian Standard Series of Patch test allergens. The allergens will be

Sponsors

Contact and Occupational Dermatoses forum of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients clinically diagnosed as allergic contact dermatitis between 18 to 70 years of age who are willing for the study

Exclusion criteria

Exclusion criteria: patients on systemic steroids and systemic immunosuppressants till 1 month before the study cancer patients

Design outcomes

Primary

MeasureTime frame
to look for positivity to patch test allergens thus confirming diagnosis of allergic contact dermatitis and causative agentsTimepoint: at 48 hours and 72 hours after patch test is applied in a single patient. The whole data will be assessed after 6 months—

Secondary

MeasureTime frame
patient education and publicationTimepoint: 2 years—

Countries

India

Contacts

Public ContactShrutakirthi D Shenoi

Kasturba Medical College

shru12@yahoo.com9480374278

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026